Article Details
Retrieved on: 2021-10-22 19:10:53
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The U.S. Food and Drug Administration on Friday approved Swiss drugmaker Roche Holding AG's eye implant for a chronic disorder causing blurred ...
Article found on: www.reuters.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here